Nifedipin Alternova (Nifedipine)

Nifedipine, the active ingredient in Nifedipin Alternova, is a calcium channel blocker presented as an oral tablet for systemic administration. It is used to lower high blood pressure, relieve chest pain from chronic stable angina, and improve blood flow in Raynaud's phenomenon, primarily in adult patients.

GNH USA supplies Nifedipin Alternova as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory documentation for importers. Products are shipped in tamper‑evident packaging to ensure integrity during transit.

Nifedipine acts as a vasodilator calcium channel blocker, used in several cardiovascular conditions.

- Hypertension: reduces peripheral vascular resistance to lower blood pressure. - Chronic stable angina: improves coronary blood flow to relieve chest pain. - Raynaud's phenomenon: alleviates vasospasm in peripheral arteries to improve blood flow.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Headache - Flushing - Peripheral edema - Dizziness

Serious or Rare Side Effects: - Severe hypotension - Myocardial infarction - Anaphylactic reaction

Before prescribing, clinicians should consider several safety aspects.

- Blood pressure monitoring: check regularly to avoid excessive hypotension. - Cardiac assessment: evaluate for underlying heart disease before use. - Hepatic function: use with caution in patients with liver impairment. - Concomitant antihypertensives: adjust doses to prevent additive blood‑pressure effects. - Discontinuation: avoid abrupt stopping to reduce risk of rebound hypertension. - Store at room temperature: keep in the original pack, protect from moisture.

Nifedipine may interact with other medicines, requiring attention to the interaction strength.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): can markedly increase nifedipine levels. - Concurrent antihypertensives: additive hypotensive effect may be dangerous. - Grapefruit juice: may raise plasma concentrations leading to toxicity.

Moderate Interactions (Monitor Closely): - Digoxin: increased serum digoxin concentrations may occur. - Statins metabolized by CYP3A4: higher risk of myopathy.